| ITALY |
WP2 |
| Organization |
University of Verona |
| Name of cohort |
Retrospective Verona COVID19 |
| Referring partner |
UNIVR |
| Cohort Information |
Country(-ies), cities, regions or centers involved |
Verona, Italy |
| Time of data collection |
03/2020
|
03/2023
|
| Enrolment |
Inactive |
| Study setting |
Single center |
| Population |
Age |
Adults,Elderly |
| Type |
Retrospective |
| Total number of patients |
430 |
| Site of enrolment (WP2) |
Inpatient
|
| Data collection |
Clinical data |
True |
| Serological data |
False |
| Genetic data |
False |
| Sample collection |
False |
| Sample collected |
Whole blood |
NA
|
| PBMC |
NA
|
| Dry-spot blood |
NA
|
| Plasma |
NA
|
| Serum |
NA
|
| Stool |
NA
|
| NP swabs |
NA
|
| Other |
NA
|
| Description |
Retrospective cohort (at the collection) that run before Orcehstra was funded. it contains 430 patients enrolled in Verona during the first wave of COVID. There are in-hospitall followup dates and extensive biochemistry. |
| Publications |
- Assessment of COVID-19 progression on day 5 from symptoms onset [BMC Infectious Diseases]
|